Charlie Kang

Charlie Kang

Charlie Kang

Chief Financial Officer
Ocugen Inc.

Charlie Kang is Chief Financial Officer of Ocugen Inc. where he is responsible for Finance and Corporate Strategy. Ocugen is a biotech company focused on developing new treatments for ocular disorders and Charlie joined in 2014 as the first employee.Prior to Ocugen, he was with Johnson & Johnson where he led Business Development for the DePuy Synthes Biologics business unit. Prior to J&J, Charlie held senior Strategy and Business Development roles at Synthes, Aspen Biopharma, and Life Technologies. Charlie started his biotech career in R&D at Somatogen Inc. developing recombinant hemoglobin-based blood substitutes. Mr. Kang obtained his MBA and his Bachelors in Molecular, Cellular, and Developmental Biology from the University of Colorado.